Furthermore, it was shown that metabolic dysfunctions, including obesity, insulin resistance, adipose tissue inflammation, lipid accumulation, and dysregulated glucose metabolism, can trigger NLRP3 inflammasome activation in various tissues, including the liver and the brain. Here, NLRP3 is linked to Insulin resistance.